Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A L Yu

Showing results (71-80 of 74) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 74 results.
Cancer Research|December 16, 2000
In vitro sensitivity of T-cell lymphoblastic leukemia to UCN-01 (7-hydroxystaurosporine) is dependent on p16 protein status: a Pediatric Oncology Group studyM Omura-Minamisawa, M B Diccianni, A Batova, et al.
Human Antibodies and Hybridomas|January 1, 1992
Phase I trial of the chimeric anti-GD2 monoclonal antibody ch14.18 in patients with malignant melanomaM N Saleh, M B Khazaeli, R H Wheeler, et al.
Gynecologic Oncology|May 1, 1997
p16INK4 and p15INK4B alterations in primary gynecologic malignancyY F Wong, T K Chung, T H Cheung, et al.
Oncogene|May 9, 2007
Human p16gamma, a novel transcriptional variant of p16(INK4A), coexpresses with p16(INK4A) in cancer cells and inhibits cell-cycle progressionY-C Lin, M B Diccianni, Y Kim, et al.
Pageof 8

Showing results (71-80 of 74) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 74 results.
Cancer Research|December 16, 2000
In vitro sensitivity of T-cell lymphoblastic leukemia to UCN-01 (7-hydroxystaurosporine) is dependent on p16 protein status: a Pediatric Oncology Group studyM Omura-Minamisawa, M B Diccianni, A Batova, et al.
Human Antibodies and Hybridomas|January 1, 1992
Phase I trial of the chimeric anti-GD2 monoclonal antibody ch14.18 in patients with malignant melanomaM N Saleh, M B Khazaeli, R H Wheeler, et al.
Gynecologic Oncology|May 1, 1997
p16INK4 and p15INK4B alterations in primary gynecologic malignancyY F Wong, T K Chung, T H Cheung, et al.
Oncogene|May 9, 2007
Human p16gamma, a novel transcriptional variant of p16(INK4A), coexpresses with p16(INK4A) in cancer cells and inhibits cell-cycle progressionY-C Lin, M B Diccianni, Y Kim, et al.
Pageof 8